Cannabis-Based drug BRC-002 enters first human safety trials
Knowledge-focused
ENROLLING_BY_INVITATION
This phase 1 study evaluates the safety and tolerability of BRC-002, an investigational cannabis-derived botanical drug, in healthy adults aged 18 to 55. Researchers will also examine how the body processes the drug and whether food affects its absorption. The results will guide …
Phase: PHASE1 • Sponsor: Biopharmaceutical Research Company • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC